dr. sonpavde on immunotherapy combination studies in urothelial carcinoma
Published 6 years ago • 109 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
0:53
dr. sonpavde on immunotherapy plus chemotherapy in bladder cancer
-
2:07
dr. sonpavde on emerging immunotherapy approaches in bladder cancer
-
1:26
dr. sonpavde on remaining questions with immunotherapy in bladder cancer
-
2:03
dr. sonpavde on immunotherapy after progression in advanced bladder cancer
-
0:52
dr. sonpavde on trials of immunotherapy in bladder cancer
-
1:24
dr. sonpavde on neoadjuvant immunotherapy in bladder cancer
-
1:25
dr. sonpavde on the next steps for atezolizumab in urothelial carcinoma
-
1:27
dr. sonpavde on enfortumab vedotin data in bladder cancer
-
1:58
dr. sonpavde on combining vegf/pd-1 inhibitors in metastatic urothelial carcinoma
-
1:10
dr. sonpavde on the potential for neoadjuvant immunotherapy in bladder cancer
-
1:04
dr. plimack on immunotherapy combinations in bladder cancer
-
1:19
dr. sonpavde on key data with immunotherapy in metastatic bladder cancer
-
1:43
dr. sonpavde discusses a study of fixed-dose durvalumab and tremelimumab in urothelial carcinoma
-
0:46
dr. sonpavde on the need for phase 3 data with pembrolizumab or atezolizumab in bladder cancer
-
0:47
copy of dr. sonpavde on key data with immunotherapy in metastatic bladder cancer
-
1:05
dr. sonpavde on the role of durvalumab in platinum-refractory bladder cancer
-
1:05
dr. sonpavde on the biggest challenges in bladder cancer
-
1:32
dr. balar discusses study of immunotherapy combination in bladder cancer
-
1:33
dr. sonpavde on novel prognostic marker for atezolizumab in bladder cancer